COVID-19 CRO SERVICES

COVID-19 CRO SERVICES

SARS-CoV-2 infection induces greater disease severity in the Physiogenex free-choice diet-induced obese NASH hamster – a metabolic comorbidities model of COVID-19

The devastating pandemic of COVID-19 (coronavirus disease 2019) is dramatically affecting every country on Earth, with millions of deaths and global economy turndown.

Obesity, type 2 diabetes and related comorbidities like NASH and heart failure are associated with the most severe forms of COVID-19 seen in humans. Therefore, preclinical animal models are urgently needed to validate therapies for obese/type 2 patients.

In collaboration with the Institut Pasteur de Lille, Physiogenex now delivers a unique metabolic comorbidities model infected with SARS-CoV-2:

the free choice diet-induced obese NASH hamster – a metabolic comorbidities model of COVID-19

To see how you could move forward quickly with your drug candidate targeting COVID-19, check the model description below:

COVID-19 experimental in vivo model

Physiogenex obese NASH hamster – a metabolic comorbidities model of Covid-19 :

CONTACT US FOR MORE INFORMATION

felis lectus ipsum ut dolor risus. et, venenatis, eleifend